Literature DB >> 15912297

Solitary metachronous metastasis to the thyroid from renal clear cell carcinoma 19 years after nephrectomy: report of a case.

Nobuyuki Wada1, Shohei Hirakawa, Yasushi Rino, Kimiatsu Hasuo, Kae Kawachi, Yukio Nakatani, Kenji Inui, Yoshinori Takanashi.   

Abstract

We report a rare case of a solitary metachronous metastasis of renal clear cell carcinoma (RCC) presenting as a thyroid tumor 19 years after a nephrectomy. Our search of the English-language literature found only sporadic reports of late RCC metastases to the thyroid. Fine-needle aspiration biopsy of the thyroid tumor was not accompanied with thyroglobulin (Tg) staining, leading us to initially suspect a primary follicular thyroid carcinoma. The patient, a 77-year-old man, underwent a total thyroidectomy with modified neck dissection. Histological examination confirmed the tumor to be RCC metastasis, and immunohistochemical analysis revealed that both Tg and thyroid transcription factor-1 (TTF-1) were negative in the tumor cells. Thus, the possibility of late RCC metastasis to the thyroid should be considered, even in a patient with a remote history. Furthermore, TTF-1 is useful for identifying thyroid metastatic carcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912297     DOI: 10.1007/s00595-004-2953-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

Review 1.  Tumor-to-tumor metastasis: Renal cell carcinoma metastatic to papillary carcinoma of thyroid-report of a case and review of the literature.

Authors:  Olga L Bohn; Luis E De las Casas; Marino E Leon
Journal:  Head Neck Pathol       Date:  2009-11-15

2.  Detection of Thyroid Metastasis of Renal Transitional Cell Carcinoma Using FDG PET/CT.

Authors:  Yong-Il Kim; Jong Jin Lee; Jin Ho Paik; Yu Kyeong Kim; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-03-22

3.  A case of metastatic renal cell carcinoma to thyroid gland.

Authors:  Jae-Geun Lee; Youngro Yang; Kwang Sik Kim; Chang Lim Hyun; Ji Shin Lee; Gwanpyo Koh; Daeho Lee
Journal:  Chonnam Med J       Date:  2011-08-31

4.  Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report.

Authors:  B Castagneto; I Stevani; L Giorcelli; F Montefiore; G L Bigatti; P Pisacco; M F Cosimi
Journal:  Med Oncol       Date:  2010-06-15       Impact factor: 3.064

Review 5.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

Review 6.  Metastatic carcinoma to the thyroid gland: a single institution 20-year experience and review of the literature.

Authors:  Parnian Ahmadi Moghaddam; Kristine M Cornejo; Ashraf Khan
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

7.  Metastatic carcinoma to the thyroid gland from renal cell carcinoma: role of ultrasonography in preoperative diagnosis.

Authors:  Kaoru Kobayashi; Mitsuyoshi Hirokawa; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroo Masuoka; Takuya Higashiyama; Minoru Kihara; Yasuhiro Ito; Akihiro Miya; Nobuyuki Amino; Akira Miyauchi
Journal:  Thyroid Res       Date:  2015-03-17

8.  Ultrasonographic characteristics of thyroid metastasis from clear cell renal cell carcinoma: A case report.

Authors:  Peng Tian; Wenyan Du; Xiaoxi Liu; Wenzhe Xu; Xiaoyue Rong; Zekai Zhang; Yanzhen Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.